Jiaying Zhang, Feng Jiao, Zhenqian Wang, Chenfeng Zou, Xiangjun Du, Dewei Ye, Guozhi Jiang
{"title":"鉴定CD209作为COVID-19感染后2型糖尿病的干预靶点:来自蛋白质组全孟德尔随机化的见解","authors":"Jiaying Zhang, Feng Jiao, Zhenqian Wang, Chenfeng Zou, Xiangjun Du, Dewei Ye, Guozhi Jiang","doi":"10.2337/db24-0677","DOIUrl":null,"url":null,"abstract":"<p><strong>Article highlights: </strong>Increasing evidence links coronavirus disease 2019 (COVID-19) infection with heightened type 2 diabetes (T2D) risk; however, the mechanisms underlying this relationship remain poorly understood. We aimed to identify mediating proteins linking COVID-19 infection with T2D, elucidating how COVID-19 might heighten T2D risk. Protein CD209 and central obesity potentially play a crucial role between COVID-19 susceptibility and T2D. Our results highlight CD209 as a potential intervention target for T2D prevention following COVID-19 infection.</p>","PeriodicalId":93977,"journal":{"name":"Diabetes","volume":" ","pages":"619-629"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Identification of CD209 as an Intervention Target for Type 2 Diabetes After COVID-19 Infection: Insights From Proteome-Wide Mendelian Randomization.\",\"authors\":\"Jiaying Zhang, Feng Jiao, Zhenqian Wang, Chenfeng Zou, Xiangjun Du, Dewei Ye, Guozhi Jiang\",\"doi\":\"10.2337/db24-0677\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Article highlights: </strong>Increasing evidence links coronavirus disease 2019 (COVID-19) infection with heightened type 2 diabetes (T2D) risk; however, the mechanisms underlying this relationship remain poorly understood. We aimed to identify mediating proteins linking COVID-19 infection with T2D, elucidating how COVID-19 might heighten T2D risk. Protein CD209 and central obesity potentially play a crucial role between COVID-19 susceptibility and T2D. Our results highlight CD209 as a potential intervention target for T2D prevention following COVID-19 infection.</p>\",\"PeriodicalId\":93977,\"journal\":{\"name\":\"Diabetes\",\"volume\":\" \",\"pages\":\"619-629\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2337/db24-0677\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2337/db24-0677","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
越来越多的证据表明,与未感染的人相比,感染2019冠状病毒病(COVID-19)的人患2型糖尿病(T2D)的风险更高。然而,这种关系背后的机制仍然知之甚少。在这项研究中,我们旨在通过蛋白质组范围的孟德尔随机化(MR)分析,系统评估3283种血浆蛋白在COVID-19易感性与T2D之间的关联中的介导作用。通过反向MR、独立数据集验证和共定位分析来验证MR结果的鲁棒性。进一步进行中介分析,量化中介效应。进行了蛋白质和t2d相关表型之间的MR分析,以增强对潜在机制的理解。最后,对鉴定的蛋白进行了药物性评价。四种与COVID-19易感性相关的蛋白(ABO、CD209、CUZD1和QXOS2)与T2D有显著的因果关系。CD209蛋白在验证和共定位分析中表现出显著的相关性,被确定为因果介导蛋白。中介分析显示,CD209显著介导了COVID-19对T2D易感性的总效应(β间接[95%CI]: 0.083[0.014-0.152], P=0.019)。进一步的磁共振分析显示CD209与糖化血红蛋白、空腹血糖、空腹胰岛素和腰臀比之间存在显著关联。药物性评价表明,CD209可与α - d -甘露糖结合,并与包括二肽基肽酶4 (DPP4)在内的9个T2D药物靶点相互作用。我们的研究结果表明,CD209可能是COVID-19感染个体预防T2D的潜在干预靶点,为COVID-19和T2D之间的病理生理学联系提供了新的见解。
Identification of CD209 as an Intervention Target for Type 2 Diabetes After COVID-19 Infection: Insights From Proteome-Wide Mendelian Randomization.
Article highlights: Increasing evidence links coronavirus disease 2019 (COVID-19) infection with heightened type 2 diabetes (T2D) risk; however, the mechanisms underlying this relationship remain poorly understood. We aimed to identify mediating proteins linking COVID-19 infection with T2D, elucidating how COVID-19 might heighten T2D risk. Protein CD209 and central obesity potentially play a crucial role between COVID-19 susceptibility and T2D. Our results highlight CD209 as a potential intervention target for T2D prevention following COVID-19 infection.